1 reports of this reaction
5.9% of all PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT reports
#8 most reported adverse reaction
EMOTIONAL DISTRESS is the #8 most commonly reported adverse reaction for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT, manufactured by Oystershell Consumer Health Inc. There are 1 FDA adverse event reports linking PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT to EMOTIONAL DISTRESS. This represents approximately 5.9% of all 17 adverse event reports for this drug.
Patients taking PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT who experience emotional distress should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EMOTIONAL DISTRESS is moderately reported among PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT users, representing a notable but not dominant share of adverse events.
In addition to emotional distress, the following adverse reactions have been reported for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT:
The following drugs have also been linked to emotional distress in FDA adverse event reports:
EMOTIONAL DISTRESS has been reported as an adverse event in 1 FDA reports for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT. This does not prove causation, but indicates an association observed in post-market surveillance data.
EMOTIONAL DISTRESS accounts for approximately 5.9% of all adverse event reports for PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT, making it a notable side effect.
If you experience emotional distress while taking PIPERONYL BUTOXIDE, PYRETHRUM EXTRACT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.